Berenberg Bank set a €42.00 ($48.84) target price on Siemens Healthineers (ETR:SHL) in a report issued on Tuesday. The brokerage currently has a buy rating on the stock.

Several other equities analysts have also issued reports on SHL. Morgan Stanley set a €34.00 ($39.53) price target on Siemens Healthineers and gave the stock a neutral rating in a research report on Wednesday, May 2nd. Royal Bank of Canada set a €34.00 ($39.53) price target on Siemens Healthineers and gave the stock a neutral rating in a research report on Wednesday, May 2nd. Kepler Capital Markets set a €36.00 ($41.86) price target on Siemens Healthineers and gave the stock a buy rating in a research report on Thursday, May 3rd. JPMorgan Chase & Co. set a €32.60 ($37.91) price target on Siemens Healthineers and gave the stock a neutral rating in a research report on Thursday, May 3rd. Finally, Deutsche Bank set a €36.00 ($41.86) target price on Siemens Healthineers and gave the stock a buy rating in a research report on Thursday, May 3rd. Twelve equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of €37.91 ($44.08).

SHL opened at €39.35 ($45.76) on Tuesday.

About Siemens Healthineers

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Recommended Story: Do You Need a Fiduciary?

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.